BAX Jan 2025 45.000 call
| Previous Close | 0.5200 |
| Open | 0.6800 |
| Bid | 0.4000 |
| Ask | 0.5500 |
| Strike | 45.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.4500 - 0.6800 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 2.8k |
- Business Wire
Baxter to Present at Jefferies 2024 Global Healthcare Conference
DEERFIELD, Ill., May 23, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, December 2, 2024.
PR NewswireBAXTER ANNOUNCES MISSION AND LOGO FOR PROPOSED KIDNEY CARE COMPANY VANTIVE
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive.
ZacksBaxter's (BAX) Clinolipid Gets FDA's Expanded Indication
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
